Drug treatments in a neonatal setting: Focus on the off-label use in the first month of life

Pharmacy World and Science

Volumn 32, Issue 2, 2010, Pages 120-124

  Dessì, Angelica ^a   Salemi, Claudia ^a   Fanos, Vassilios ^a   Cuzzolin, Laura ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Italy; Medicines; Newborn; Off label prescribing

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; BECLOMETASONE; BETAMETHASONE; BUDESONIDE; CAFFEINE; CEFIXIME; CEFTRIAXONE; FERROUS SULFATE; FUROSEMIDE; GENTAMICIN; MICONAZOLE; PARACETAMOL; PIPERACILLIN; RANITIDINE; SALBUTAMOL;

ARTICLE; DRUG INDICATION; DRUG INFORMATION; DRUG MARKETING; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LICENCE; MAJOR CLINICAL STUDY; MALE; NEWBORN CARE; NEWBORN INTENSIVE CARE; OFF LABEL DRUG USE; PILOT STUDY; PRESCRIPTION; TREND STUDY;

AGE FACTORS; BODY WEIGHT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; ITALY; MALE; OFF-LABEL USE; PILOT PROJECTS; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 77953325078     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-009-9356-2     Document Type: Article

References (10)

1. Conroy S, McIntyre J, Choonara I. Unlicensed and off-label drug use in neonates. Arch Dis Child Fetal Neonat. 1999;80:F142-5.
2. Burns JP. Research in children. Crit Care Med. 2003;31(suppl. 3):S131-6.
3. Choonara I, Conroy S. Unlicensed and off-label drug use in children: implications for safety. Drug Saf. 2002;25:1-5.
4. Ceci A, Felisi M, Baiardi P, Bonifazi F, Catapano M, Giaquinto C, et al. Medicines for children licensed by the European Medicine Agency (EMEA): the balance after 10 years. Eur J Clin Pharmacol. 2006;62:947-52.
5. Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Exp Opin Drug Saf. 2006;5:703-18.
6. Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, et al. Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Weekly. 2006;136: 218-22.
7. Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci. 2007;29: 361-7.
8. Conroy S, McIntyre J. The use of unlicensed and off-label medicines in the neonate. Semin Fetal Neonat Med. 2005;10: 115-22.
9. Rieger-Fackeldey E, Reinhardt D, Schulze A. Effects of inhaled formoterol compared with salbutamol in ventilated preterm infants. Pulm Pharmacol Ther. 2004;17:293-300.
10. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52:77-83.